ENDV
Endonovo Therapeutics Inc

107
Mkt Cap
$180,756.00
Volume
999,999.00
52W High
$0.0003
52W Low
$0.00
PE Ratio
-0.02
ENDV Fundamentals
Price
$0.0001
50D MA
$0.0001
Beta
-29.29
Avg. Volume
1.45M
EPS (Annual)
-$0.0051
P/B
-0.00
$7.09
Loading...
Loading...
Endonovo Therapeutics, Inc. is a biotechnology company, which engages in the development, manufacture, and distribution of medical devices focused on the rapid healing of wounds and reduction of pain, edema, and inflammation on and in the human body. Its technology and products include Electroceuticals, EFECT Trial, and SofPulse Electroceutical Therapy. The company was founded in November 2008 and is headquartered in Woodland Hills, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Endonovo Therapeutics Inc?
What is the 52-week high for Endonovo Therapeutics Inc?
What is Endonovo Therapeutics Inc stock price today?
What is the PE ratio of Endonovo Therapeutics Inc?
What is the Price-to-Book ratio of Endonovo Therapeutics Inc?
What is the 50-day moving average of Endonovo Therapeutics Inc?

Latest ENDV News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.